Inhibikase Therapeutics is a pharmaceutical company that develops neurodegenerative disease treatments. It provides a re-engineering approach with a metabolism preserved (RAMP) drug innovation engine developing protein kinase inhibitors for the treatment of kinase-sensitive CNS diseases.